共 12 条
- [1] Isaccs A., Lindenmann J., Virus interference. I. The interferons, Proceedings of the Royal Society B: Biological Sciences, 147, pp. 258-267, (1957)
- [2] Hoofnagle J.H., Mullen K.D., Jones D.B., Et al., Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon, N Engl J Med, 315, pp. 1575-1578, (1986)
- [3] Fentiman I.S., Thomas B.S., Balkwill F.R., Et al., Primary hypothyroidism associated with interferon therapy of breast cancer, Lancet, 1, (1985)
- [4] Burman P., Karlsson F.A., Oberg K., Et al., Autoimmune thyroid disease in interferon-treated patients, Lancet, 2, pp. 100-101, (1985)
- [5] Bevan P.C., Interferon-induced parotitis and epididymitis, Lancet, 2, (1985)
- [6] McLaughlin P., Talpaz M., Quesada J.R., Et al., Immune thrombocytopenia following α-interferon therapy in patients with cancer, JAMA, 254, pp. 1353-1354, (1985)
- [7] Ronnblom L.E., Alm G.V., Oberg K.E., Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors, Ann Intern Med, 115, pp. 178-183, (1991)
- [8] Renault P.F., Hoofnagle J.H., Side effects of alpha interferon, Semin Liver Dis, 9, pp. 273-277, (1989)
- [9] Akard L.P., Hoffman R., Elias L., Et al., Alpha-interferon and immune hemolytic anemia, Ann Intern Med, 105, (1986)
- [10] Fornaciari G., Bassi C., Beltrami M., Et al., Hemolytic anemia secondary to interferon treatment for chronic B hepatitis, J Clin Gastroenterol, 13, pp. 596-597, (1991)